Keywords: NPH انسولین; EIA; enzyme immunoassay; GLP-1; glucagon-like peptide-1; PEG; polyethylene glycol; NPH insulin; neutral protamine Hagedorn insulin; Type 2 diabetes; Insulin antibodies; Glargine; Detemir; Lispro; Aspart;
مقالات ISI NPH انسولین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes
Keywords: NPH انسولین; NPH insulin; NPH resuspension; Premixed insulin;
Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100Â U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials
Keywords: NPH انسولین; Patient-reported outcomes; Type 1 diabetes; Insulin glargine 100Â U/mL; NPH insulin; Diabetes Treatment Satisfaction Questionnaire; Insulin therapy;
Original ResearchReplacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Sat
Keywords: NPH انسولین; A1C; blood glucose; glargine insulin; hypoglycemia; NPH insulin; patient satisfaction; A1c; glycémie; insuline glargine; hypoglycémie; insuline NPH; satisfaction des patients;
Estudio observacional de eficacia y seguridad del cambio de insulina NPH a glargina en atención primaria. Estudio LAURA
Keywords: NPH انسولین; Diabetes mellitus tipo 2; Atención primaria; Insulina glargina; Insulina NPH; Hipoglucemias; Control glucémicoType 2 diabetes mellitus; Primary care; Insulin glargine; NPH insulin; Hypoglycaemias; Blood glucose control
Impacto económico y sanitario de las hipoglucemias nocturnas asociadas al tratamiento de la diabetes mellitus tipo 2 con insulina glargina o insulina NPH
Keywords: NPH انسولین; Insulina glargina; Insulina NPH; Diabetes mellitus; Hipoglucemias nocturnas; Análisis de costesGlargine insulin; NPH insulin; Diabetes mellitus; Nocturnal hypoglycemia; Costs analysis
Bioavailability and variability of biphasic insulin mixtures
Keywords: NPH انسولین; Absorption kinetics; Subcutaneous depot; Rapid acting insulin analogue; NPH insulin; Insulin crystals;
Absorption kinetics of insulin after subcutaneous administration
Keywords: NPH انسولین; Insulin absorption; Soluble insulin; NPH insulin; Dose size effect; Insulin concentration effect; Crystal parameter effect
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: A meta-analysis
Keywords: NPH انسولین; Meta-analysis; Type 2 diabetes mellitus; Long-acting insulin; NPH insulin
Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes
Keywords: NPH انسولین; Repaglinide; Metformin; NPH insulin; Type 2 diabetes; Glycemic control
Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Keywords: NPH انسولین; Type 2 diabetes; Insulin glargine; NPH insulin; Glycemic control
Les nouvelles insulines : intérêts et inconvénients
Keywords: NPH انسولین; Insulinothérapie; Analogues rapides de l'insuline; Analogues lents de l'insuline; Schéma basal-bolus; Insuline aspart; Insuline lispro; Insuline glulisine; Insuline glargine; Insuline détémir; Insuline NPH; Insulinotherapy; Rapid acting insulin analog
Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride 12
Keywords: NPH انسولین; Type 2 diabetes; Insulin glargine; NPH insulin; Glimepiride; Hypoglycemia; Glycemic control
Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?
Keywords: NPH انسولین; Insulin effects; Reproducibility; Glycemic variability; Insulin analogs; Insulin detemir; Insulin glargine; NPH insulin; Effets de l'insuline; Reproductibilité; Variabilité glycémique; Analogues de l'insuline; Insuline détémir; Insuline glargine;